The objective of this study was to determine the role and mechanism of S-phase kinase-associated protein 2 (Skp2) in colorectal cancer cell proliferation and survival both in vitro and in vivo. Adenoviral vector expressing Skp2 short hairpin RNA was transduced into SW480 cells. The effects of Skp2 on cell cycle and survival were assessed by Flow Cytometry. Cell proliferation was analyzed by MTT assay. The expression of cell cycle regulators p16 and p27 were measured by western blot. In vivo, human colorectal cancer was produced by xenograft of cancer cells in nude mouse. Tumor growth inhibitory rate was calculated to generate growth curve. Tumor growth was monitored by examining proliferating cell nuclear antigen expression, whereas tumor cell apoptosis was detected by TdT-mediated dUTP nick-end labeling (TUNEL) staining. Knockdown of Skp2 blocked SW480 tumor cell growth and induced cell apoptosis. Skp2 appeared to be very important for the progression of cell cycle at G1/S phase. In vivo, blockade of Skp2 expression inhibited tumor growth and induced tumor apoptosis. Mechanistically, Skp2 regulated the expression of both p27 and p16 both in vitro and in vivo. The conclusion that we derive from this study is that Skp2 regulates colorectal cancer cell growth by inhibiting the expression of cell cycle regulator p27 and p16.
INTRODUCTION
Colorectal cancer is one of the most common digestive malignant tumors, and has an upward trend in morbidity and mortality in recent years. 1 Surgery is still the best curative treatment option at present. But many patients develop tumor recurrence after surgery and the 5-year survival rate is very low. Therefore, it is very important to explore mechanisms underlying the tumorigenesis and develop effective treatment for colorectal cancer.
Dysregulation of cell cycle is one of the mechanisms underlying the tumorigenesis. 2 Excessive cell proliferation and apoptosis resistance are observed in a variety of human tumors. [3] [4] [5] [6] [7] [8] One of the key regulators involved in cell cycle progression is F-box protein, S-phase kinase-associated protein 2 (Skp2). Skp2 participates in cell cycle regulation by mediating ubiquitination and subsequent degradation of CDKI. Recent studies suggest that Skp2 is associated with the development of a number of human cancers. However, the role of Skp2 in the progression of colorectal cancer is not clearly established.
In the present study, we have explored the role of Skp2 on the proliferation of colorectal cancer cell SW480 in vitro and the progression of colorectal cancer in vivo. We have found that Skp2 has an important role in the proliferation and apoptosis of colorectal cancer cells.
MATERIALS AND METHODS

Cell culture
Human colorectal cancer SW480 cells were obtained from the Department of Cardiology and Institute of Clinical Medicine, Renmin Hospital of Hubei University of Medicine (Hubei, China). The cells were cultured in RPMI 1640 containing 10% FBS at 37 1C in a humidified atmosphere with 5% CO 2 .
Construction of Skp2 short hairpin RNA (shRNA) adenoviral vector: Skp2 and control shRNAs were published and widely used. 9 The shRNA sequences were 5 0 -CGCGTCGTTCTCTCGATTTAGCTTAGGCTTCAAGAGAGCC TAAGCTAAATCGAGAGAACTTTTTTGGAAA-3 0 (sense), and 5 0 -AGCTTTTCAA AAAGTTCTCTCGATTTAGCTTAGGCTCTCTTGAAGCCTAAGCTAAATCGAGAGA ACGA-3 0 (antisense). The double-stranded DNA fragment was cloned into the MluI/HindIII restriction site of the pShuttle-H1.1/adenovector (GenScript Corporation, Piscataway, NJ, USA), resulting in pShuttle-H1.1-shSkp2. The inserted sequences were verified by restricted enzyme digestion and DNA sequencing. Adenovirus-expressing shSkp2 was packaged in BJ5183-AD-1 (Agilent, Santa Clara, CA, USA) and propagated in AD-293 cells (Invitrogen, Grand Island, NY, USA) by following the manufacturer's instruction. The adenovirus was purified by cesium chloride density gradient centrifugation. 10 
Adenovirus transduction
Transduction of human colorectal cancer SW480 cells with adenovirus were carried out according to the method of Tang et al. 11 Briefly, SW480 cells were infected with negative control (NC) shRNA or Ad-shSkp2, at 100 multiplicity of infection.
Western blot
Thirty micrograms of cell lysates or tissue protein samples were separated in a 12% polyacrylmide gel and transferred onto a nitrocellulose membrane (Millipore, Billerica, MA, USA). The membrane was rinsed in tris-buffered saline (TBS) containing 0.1% Tween-20 (TBST) and blocked with 5% fat-free milk in TBS at room temperature for 1 h. The membrane was then incubated with anti-Skp2, anti-p27, anti-p16 (Santa Cruz, Santa Cruz, CA, USA) or anti-a-tubulin antibody (Sigma, St Louis, MO, USA); 1:500, 1 1:500, 1:500 and 1:5000 dilution, respectively) followed by incubation with horseradish peroxidase-conjugated secondary antibodies (1:10 000 dilution; Santa Cruz). The immunoblots were detected by enhanced chemiluminescence reaction (Amersham Pharmacia Biotech, Morgan Baie-D'Urfé , QC, Canada) and measured with densitometry.
MTT assay
Cells were cultured on 96-well plates (Beyotime, Jiang-Su, China) at 5 Â 10 3 cells per well in RPMI 1640 supplemented with 10% FBS. Cell proliferation was analyzed by MTT assay using the MTT reagents (3-(4, 5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) purchased from Sigma.
Cell cycle analysis and apoptosis assay Cells were seeded at 1.0 Â 10 6 cells per well in six-well plates, cultured for 48 h and then harvested, further 1 ml of 70% ethanol was added precooling at À 20 1C overnight. The percentage of cells at G1 and S phases was determined by flow cytometry. For apoptosis analysis, the cells were incubated with 1 ml of propidium iodide in dark at 4 1C for 20 min and then subjected to flow cytometry to measure apoptosis rate (percentage). The experiments were repeated for three times.
In vivo tumor growth inhibition assay . To test the growth inhibitory effect of Ad-Skp2-shRNA on SW480 xenografts in the nude mice, intratumoral injection of PBS, NC adenovirus, or Ad-Skp2-shRNA was performed every 3 days for times in total. Each group had six mice. The animals were monitored for tumor formation every 3 days and experiment ended 4 weeks later. Tumor sizes were measured at the end of the experiment. Tumor volume was estimated by the formula: p/6 Â a 2 Â b, where a is the short axis and b is the long axis.
Hematoxylin and eosin staining and immunohistochemistry
The nude mice xenografts of SW480 specimen sections were subjected to hematoxylin and eosin staining. For immunohistochemistry (IHC) staining, the specimen sections were rehydrated, blocked with 5% goat serum and permeabilized with 0.01% Triton X-100 in PBS, and incubated with proliferating cell nuclear antigen (PCNA) antibodies overnight at 4 1C followed by incubation with horseradish peroxidase-conjugated secondary antibodies. The PCNA expressions were visualized by 3, 3 0 diaminobenzidine staining, and the sections were counterstained with hematoxylin.
In vivo cell apoptosis assay Cell apoptosis in xenografts was detected using a TUNEL assay kit (Chemicon, Billerica, MA, USA) by following the manufacturer's instructions. SW480 xenografts sections were fixed with 4% paraformaldehyde for 30 min at room temperature. After washing with PBS, the sections were treated with 0.1% Triton X-100 in PBS for 2 min and then incubated with 50 ml TUNEL solution in dark at 37 1C for 60 min. The sections were washed twice with PBS. The apoptotic cells were observed with inverted fluorescence microscope. 12 
Statistical analysis
All data were expressed as mean±s.d. Comparisons were made with a one-way analysis of variance followed by Student's t-test using SPSS Software (version 17.0, Athens, GA, USA). Po0.05 was considered statistically significant.
RESULTS
Skp2 was important for the proliferation of colorectal cancer cells
In order to determine the role of Skp2 in the progression of colorectal cancer, we knocked down its expression using adenovirusexpressing Skp2 shRNA. The adenovirus can be successfully a b
Ad-NC Ad-shSkp2 transduced into SW480 cells (Figures 1a and b) . The expression of Skp2 was effectively blocked by the shRNA (Figure 1c) . Importantly, downregulation of Skp2 significantly inhibited SW480 cell proliferation (Figure 1d ). This result demonstrated that Skp2 has an important role in colorectal cancer cell growth.
Skp2 promoted colorectal cancer cell proliferation by regulating cell cycle and apoptosis To determine how Skp2 regulates colorectal cancer cell proliferation, we tested its effect on SW480 cell cycle and apoptosis using flow cytometry. Knockdown of Skp2 by shRNA caused cell cycle arrest at G1 phase (Figure 2a) , suggesting that Skp2 is involved in cell cycle regulation of SW480 cells. In addition, knockdown of Skp2 resulted in a significant increase in cell apoptosis rate (21.3%) as compared with blank control (PBS, 3.1%) or NC shRNA (Skp2-NC, 3.9%) (Figures 2b and d) . These data indicate that Skp2 is important for the proliferation and survival of colorectal cancer cells.
Skp2 promotes colorectal cancer cell proliferation by regulation of p27 and p16 As Skp2 knockdown altered SW480 cell cycle, we tested whether Skp2 regulated the expression of cell cycle regulators. p27 and p16 are critical negative regulators for cell cycle progression. Previous studies have shown that p27 has a very important role in blocking SW480 cell proliferation. It appeared that Skp2 promoted SW480 cell growth through inhibiting p27 expression because knockdown of Skp2 significantly increased p27 expression (Figures 3a and d) . In addition, we found that blockade of Skp2 significantly upregulated p16 protein expression (Figures 3a and  d) . These data suggest that Skp2 promotes colorectal cancer cell growth through inhibiting the expression of both p27 and p16. 
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Knockdown of Skp2 inhibits tumor growth in vivo
To test whether Skp2 is important for colorectal cancer cell growth in vivo and to explore the therapeutic effect of Skp2-shRNA, we generated colorectal cancer animal model by implanting SW480 cells on nude mice. As shown in Figures 4a and b , SW480 grew rapidly in nude mice treated with PBS (3.4 ± 0.3 g) or NC shRNA (3.3 ± 0.4 g). However, knockdown of Skp2 significantly blocked the tumor growth (2.3±0.3 g) (Figures 4a and b) . Skp2-shRNA reduced the tumor growth by 32.4% (Figure 4c ).
Knockdown of Skp2 blocked cell proliferation marker gene expression In order to further determine if Skp2 has a role in the proliferation of colorectal cancer cells in vivo, we measured the expression of PCNA transplanted tumor specimens by IHC. As shown in Figures  5a and b , knockdown of Skp2 significantly decreased the number of cells expressing PCNA, further demonstrating that Skp2 has an important role in colorectal cancer growth in vivo.
Skp2 inhibited p27 and p16 expression in nude mouse xenograft As p27 and p16 is involved in Skp2-mediated SW480 cell proliferation, we sought to determine whether Skp2 promotes colorectal tumor growth in vivo. As shown in Figures 6a and b , knockdown of Skp2 significantly increased p27 and p16 expression in the tumor tissues. These results indicate that Skp2 stimulated colorectal tumor growth by inhibiting p27 and p16 expression.
Knockdown of Skp2 induced tumor cell apoptosis in vivo Blockade of apoptosis contributes to tumorigenesis. In vitro study showed that Skp2 is involved in SW480 cell survival. To confirm this phenomenon in vivo, we detected cell apoptosis of tumor by TUNEL assay. As shown in Figures 7a and b , PBS or NC shRNA Figure 6 . Effect of S-phase kinase-associated protein 2 (Skp2) on p27 and pl6 expression in transplanted tumors. (a) Skp2 and p27, pl6 protein levels in transplanted tumors were detected by western blot analysis. PBS, negative control shRNA (Skp2-NC) or Skp2-short hairpin RNA (shRNA) was injected in tumor xenografts for three times followed by western blot analysis, a-tubulin served as an internal control. (b-d) Quantitative analysis of the protein expression in a by normalized to a-tubulin. *Po0.05 compared with PBS and negative control shRNAtreated group (Skp2-NC) groups, n ¼ 5. (Skp2-NC) treatment did not induce apoptosis in the tumor tissue. However, Skp2-shRNA significantly increased the number of cells undergoing apoptosis (Figure 7c ). The apoptosis rate in Skp2-shRNA-treated cells (10.07±1.07%) was much higher compared with PBS (1.54 ± 0.14%) or Skp2-NC treatment (2.06 ± 0.17%) (Figure 7d ). These results suggest that Skp2 has a very important role in colorectal cancer cell survival in vivo.
DISCUSSION
Skp2 mediates ubiquitination and subsequent degradation of CDKI, and regulates cell cycle from G1 to S phase. CDKI family member p27 and p16 negatively regulate cell cycle. Enhanced proteolysis of p27 and p16 Skp2 promotes G1/S phase transformation, leading to cell proliferation and oncogenesis. High level of Skp2 and low level of p27 are previously observed in a variety of human malignant tumors, indicating the importance of the Skp2-p27 axis in tumorigenesis. [6] [7] [8] [13] [14] [15] Our studies confirm that downregulation of Skp2 is associated with the accumulation of p27 in colorectal cancers. More importantly, our studies have made novel finding that Skp2 promotes colorectal cancer growth by downregulation of both p27 and p16.
Skp2 appears to be important for both the proliferation and survival of the colorectal cancer cells. Downregulation of Skp2 induces cell cycle arrest at G1/S phase. Moreover, Skp2 is important for PCNA expression. PCNA is involved in DNA replication and methylation. A low level of PCNA is found in quiescent cells, whereas a high level of PCNA is present in cells at the late G1 and S phase. Downregulation of Skp2 causing decreased expression of PCNA is consistent with its role in cell cycle. In addition to proliferation, Skp2 is important for colorectal cancer cell survival because knockdown of Skp2 induces apoptosis both in vitro and in vivo. Our results suggest that Skp2 is a target for designing novel gene therapy for treating human colorectal cancer.
In this study, we found that Skp2 regulates colorectal cancer cell growth by inhibiting the expression of cell cycle regulator p27 and p16. Knockdown of Skp2 blocked SW480 tumor cell growth and induced cell apoptosis. Skp2 appeared to be very important for the progression of cell cycle at G1/S phase. In vivo, blockade of Skp2 expression inhibited tumor growth and induced tumor apoptosis. Mechanistically, Skp2 regulated the expression of both p27 and p16 both in vitro and in vivo.
